|
From Our Web Site
Collaborative Funding Grants last year went to: NC State and Advanced Animal Diagnostics; UNC-Chapel Hill and Entegrion; Duke and Phase Bio; Duke and Entex Technologies; and the Hamner Institutes and Zen-Bio.
Metabolon, a Research Triangle Park company that develops biomarkers for disease detection, has begun offering a test that may how aggressive a case of prostate cancer is.
Pioneer Surgical Technology, which has a research facility in Greenville, has won the prestigious Frost & Sullivan 2009 North American Technology Innovation of the Year Award for its E-Matrix Tissue Scaffold. The company received early funding from the Biotechnology Center.
Chinese regulators have given marketing approval to a new bone-graft material from Biocomposites, a British firm with U.S. headquarters in Wilmington.
Forsyth County-based Muscadine Naturals has launched a new product containing Muscadine grape skins and seed powder. The company expects the product to prove useful against heart disease.
Duke University scientists have isolated a rare antibody that appears to stifle HIV, providing a possible basis for developing a new kind of vaccine.
The celebration highlighted achievements in economic development, research and education.
Technomark, a multi-national firm with headquarters in RTP, takes a new approach to product development.
Charlotte stent maker Alveolus has been sold to Merit Medical Systems of South Jordan, Utah, for $19 million. Most employees are expected to remain in Charlotte.
Duane Larick, Ph.D., interim dean of North Carolina State University's Graduate School and a professor of food, bioprocessing and nutrition sciences, has been named dean of the Graduate School, effective March 1.
|